José Baselga joins Verastem's SAB
This article was originally published in Scrip
Executive Summary
Verastem, a biopharmaceutical company developing drugs to treat breast and other cancers by targeting cancer stem cells, has elected Dr José Baselga, a renowned breast cancer specialist, to its scientific advisory board. Dr Baselga is currently the Bruce A. Chabner chair and chief of the division of haematology/oncology at Massachusetts General Hospital and associate director of the MGH Cancer Center.